chr17-42536273-A-T

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_000263.4(NAGLU):​c.1A>T​(p.Met1?) variant causes a initiator codon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000164 in 1,216,526 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 9.4e-7 ( 0 hom. )

Consequence

NAGLU
NM_000263.4 initiator_codon

Scores

6
3
7

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 0.322
Variant links:
Genes affected
NAGLU (HGNC:7632): (N-acetyl-alpha-glucosaminidase) This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PVS1
Start lost variant, next in-frame start position is after 16 pathogenic variants. Next in-frame start position is after 157 codons. Genomic position: 42537483. Lost 0.210 part of the original CDS.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-42536273-A-T is Pathogenic according to our data. Variant chr17-42536273-A-T is described in ClinVar as [Pathogenic]. Clinvar id is 3759435.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NAGLUNM_000263.4 linkc.1A>T p.Met1? initiator_codon_variant Exon 1 of 6 ENST00000225927.7 NP_000254.2 P54802A0A140VJE4
NAGLUXM_047436138.1 linkc.-461A>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 5 XP_047292094.1
NAGLUXM_024450771.2 linkc.1A>T p.Met1? initiator_codon_variant Exon 1 of 7 XP_024306539.1
NAGLUXM_047436138.1 linkc.-461A>T 5_prime_UTR_variant Exon 1 of 5 XP_047292094.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NAGLUENST00000225927.7 linkc.1A>T p.Met1? initiator_codon_variant Exon 1 of 6 1 NM_000263.4 ENSP00000225927.1 P54802
NAGLUENST00000586516.5 linkc.-251A>T upstream_gene_variant 2 ENSP00000467135.1 K7ENX5
ENSG00000266929ENST00000585572.1 linkn.-237A>T upstream_gene_variant 4

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152034
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
9.39e-7
AC:
1
AN:
1064492
Hom.:
0
Cov.:
30
AF XY:
0.00000199
AC XY:
1
AN XY:
502696
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000110
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152034
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74270
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Mucopolysaccharidosis, MPS-III-B;C5569050:Charcot-Marie-Tooth disease axonal type 2V Pathogenic:1
Jul 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change affects the initiator methionine of the NAGLU mRNA. The next in-frame methionine is located at codon 157. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with mucopolysaccharidosis type III (PMID: 9950362, 18218046). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.58
D
BayesDel_noAF
Pathogenic
0.60
CADD
Benign
17
DANN
Benign
0.65
DEOGEN2
Benign
0.19
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.66
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.98
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Uncertain
0.28
D
PROVEAN
Benign
0.010
N
REVEL
Uncertain
0.55
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.0010
B
Vest4
0.86
MutPred
0.97
Loss of catalytic residue at M1 (P = 8e-04);
MVP
0.63
ClinPred
0.97
D
GERP RS
1.0
Varity_R
0.85
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1325661354; hg19: chr17-40688291; API